Point72 Hong Kong LTD Black Diamond Therapeutics, Inc. Call Options Transaction History
Point72 Hong Kong LTD
- $1.5 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BDTX
# of Institutions
94Shares Held
41.1MCall Options Held
45.1KPut Options Held
37K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$24.3 Million0.01% of portfolio
-
Vestal Point Capital, LP New York, NY5.6MShares$13.1 Million0.62% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$10.4 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$7.53 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.73MShares$6.4 Million0.1% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $85M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...